無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

シリンジ・ニードル:パイプライン分析

Syringes and Needles - Medical Devices Pipeline Assessment, 2018

発行 GlobalData 商品コード 336431
出版日 ページ情報 英文 181 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.93円で換算しております。
Back to Top
シリンジ・ニードル:パイプライン分析 Syringes and Needles - Medical Devices Pipeline Assessment, 2018
出版日: 2018年07月01日 ページ情報: 英文 181 Pages
概要

当レポートでは、世界各国の企業・医療機関などで開発中のシリンジ・ニードルのパイプライン製品情報について分析し、治験/製品開発の全体的な進行状況や、段階別・地域別・分野別の詳細動向、企業別・製品別の詳細情報 (治験の進行段階、開始/終了時期、認証見通しなど)、昨今の製品開発・資本取引の動きなどを盛り込んでお届けいたします。

第1章 目次

第2章 イントロダクション

  • シリンジ・ニードルの概要

第3章 開発中の製品

  • パイプライン製品:開発段階別
  • パイプライン製品:セグメント別
  • パイプライン製品:地域別
  • パイプライン製品:規制経路別
  • パイプライン製品:認証時期別 (推定)

第4章 シリンジ・ニードル:開発中のパイプライン製品 (企業別)

  • シリンジ・ニードルの開発企業:パイプライン製品 (開発段階別)
  • シリンジ・ニードル:開発段階別のパイプライン製品の一覧

第5章 シリンジ・ニードルの開発企業・製品の概要

  • Children's Hospital Boston
    • パイプライン製品および進行中の治験の概要
  • Cornell University
  • Globe Medical Tech, Inc.
  • MedPro Safety Products, Inc.
  • Micropoint Technologies Pte Ltd
  • Olberon Medical Innovation SAS
  • Protectus Medical Devices, Inc.
  • Resultados y Calidad del Sistema Sanitario Publico de Andalucia
  • Syrindicare, Inc
  • Telezon Ltd
  • Unilife Corporation
  • Universitat Politecnica de Catalunya
  • University of South Florida

第6章 シリンジ・ニードル:昨今の市場動向

第7章 付録

図表一覧

図表

1.1 List of Tables

  • Table 1: Syringes and Needles - Pipeline Products by Stage of Development 11
  • Table 2: Syringes and Needles - Pipeline Products by Segment 12
  • Table 3: Syringes and Needles - Pipeline Products by Territory 13
  • Table 4: Syringes and Needles - Pipeline Products by Regulatory Path 14
  • Table 5: Syringes and Needles - Pipeline Products by Estimated Approval Date 15
  • Table 6: Syringes and Needles Companies - Pipeline Products by Stage of Development 16
  • Table 7: Syringes and Needles - Pipeline Products by Stage of Development 18
  • Table 8: Aquabiliti Pipeline Products & Ongoing Clinical Trials Overview 20
  • Table 9: Aquastat SFR 20 mL Pre-Filled Flush Syringe - Product Status 20
  • Table 10: Aquastat SFR 20 mL Pre-Filled Flush Syringe - Product Description 20
  • Table 11: Aquastat SFR 5 mL Pre-Filled Flush Syringe - Product Status 21
  • Table 12: Aquastat SFR 5 mL Pre-Filled Flush Syringe - Product Description 21
  • Table 13: ARTE CORPORATION Pipeline Products & Ongoing Clinical Trials Overview 22
  • Table 14: Lyophilized Dual Chamber Prefillable Syringe - Product Status 22
  • Table 15: Lyophilized Dual Chamber Prefillable Syringe - Product Description 22
  • Table 16: Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview 23
  • Table 17: ENFit Enteral Syringe - Product Status 23
  • Table 18: ENFit Enteral Syringe - Product Description 23
  • Table 19: Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview 24
  • Table 20: BD Hylok - Product Status 24
  • Table 21: BD Hylok - Product Description 24
  • Table 22: BD UltraSafe Plus Line Extention - Product Status 25
  • Table 23: BD UltraSafe Plus Line Extention - Product Description 25
  • Table 24: Smart Pen Needle - Product Status 25
  • Table 25: Smart Pen Needle - Product Description 25
  • Table 26: Cincinnati Children's Hospital Medical Center Pipeline Products & Ongoing Clinical Trials Overview 26
  • Table 27: Blood Specimen Collection Syringe - Product Status 26
  • Table 28: Blood Specimen Collection Syringe - Product Description 26
  • Table 29: Pre-Filled Syringe With Flush - Product Status 27
  • Table 30: Pre-Filled Syringe With Flush - Product Description 27
  • Table 31: Daxor Corp Pipeline Products & Ongoing Clinical Trials Overview 28
  • Table 32: Max-200 - Product Status 28
  • Table 33: Max-200 - Product Description 28
  • Table 34: Galderma SA Pipeline Products & Ongoing Clinical Trials Overview 29
  • Table 35: Restylane Syringe - Product Status 29
  • Table 36: Restylane Syringe - Product Description 29
  • Table 37: Globe Medical Tech Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 38: Dual Chamber Safety Prefillable Syringe - Product Status 30
  • Table 39: Dual Chamber Safety Prefillable Syringe - Product Description 30
  • Table 40: Safety Butterfly Needle - Product Status 31
  • Table 41: Safety Butterfly Needle - Product Description 31
  • Table 42: Single Chamber Safety Prefillable Syringe - Product Status 31
  • Table 43: Single Chamber Safety Prefillable Syringe - Product Description 31
  • Table 44: Injeq Oy Pipeline Products & Ongoing Clinical Trials Overview 32
  • Table 45: INJEQ IQ-Tip Spinal Needle - Product Status 32
  • Table 46: INJEQ IQ-Tip Spinal Needle - Product Description 32
  • Table 47: iScience Interventional Inc Pipeline Products & Ongoing Clinical Trials Overview 33
  • Table 48: iScience Smart Needle - Product Status 33
  • Table 49: iScience Smart Needle - Product Description 33
  • Table 50: Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 34
  • Table 51: Hybrid Needle System - Product Status 34
  • Table 52: Hybrid Needle System - Product Description 34
  • Table 53: Medigard Ltd Pipeline Products & Ongoing Clinical Trials Overview 35
  • Table 54: Manual Retractable Syringe, 3ml - Product Status 35
  • Table 55: Manual Retractable Syringe, 3ml - Product Description 36
  • Table 56: Manual Retractable Syringe, 5ml - Product Status 36
  • Table 57: Manual Retractable Syringe, 5ml - Product Description 36
  • Table 58: Pre-Filled Auto Retract Syringe - Product Status 37
  • Table 59: Pre-Filled Auto Retract Syringe - Product Description 37
  • Table 60: MonuMedical LLC Pipeline Products & Ongoing Clinical Trials Overview 38
  • Table 61: DoubleDrive Syringe - Product Status 38
  • Table 62: DoubleDrive Syringe - Product Description 38
  • Table 63: Neuroelectrics Pipeline Products & Ongoing Clinical Trials Overview 39
  • Table 64: Curved Syringe - Product Status 39
  • Table 65: Curved Syringe - Product Description 39
  • Table 66: NuvOx Pharma LLC Pipeline Products & Ongoing Clinical Trials Overview 40
  • Table 67: Syringe Sonication Device - Product Status 40
  • Table 68: Syringe Sonication Device - Product Description 40
  • Table 69: Olberon Medical Innovation SAS Pipeline Products & Ongoing Clinical Trials Overview 41
  • Table 70: Intelliderm - Product Status 41
  • Table 71: Intelliderm - Product Description 41
  • Table 72: Protectus Medical Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42
  • Table 73: Safety Dental Syringe - Product Status 42
  • Table 74: Safety Dental Syringe - Product Description 42
  • Table 75: Resultados y Calidad del Sistema Sanitario Publico de Andalucia Pipeline Products & Ongoing Clinical Trials Overview 43
  • Table 76: Syringe - Product Status 43
  • Table 77: Syringe - Product Description 43
  • Table 78: Rutgers The State University of New Jersey Pipeline Products & Ongoing Clinical Trials Overview 44
  • Table 79: Jersey Safety Syringe - Product Status 44
  • Table 80: Jersey Safety Syringe - Product Description 44
  • Table 81: Silmag SA Pipeline Products & Ongoing Clinical Trials Overview 45
  • Table 82: Peel Off Introducer (Standard/Silflash) - Product Status 45
  • Table 83: Peel Off Introducer (Standard/Silflash) - Product Description 45
  • Table 84: Syrindicare, Inc Pipeline Products & Ongoing Clinical Trials Overview 46
  • Table 85: SYRINDICARE Syringe - Product Status 46
  • Table 86: SYRINDICARE Syringe - Product Description 46
  • Table 87: Telezon Ltd Pipeline Products & Ongoing Clinical Trials Overview 47
  • Table 88: DuoDraw Transfer and Injection Device - Product Status 47
  • Table 89: DuoDraw Transfer and Injection Device - Product Description 47
  • Table 90: PolyDermic Plastic Hypodermic Needle - Product Status 48
  • Table 91: PolyDermic Plastic Hypodermic Needle - Product Description 48
  • Table 92: Unilife Corporation Pipeline Products & Ongoing Clinical Trials Overview 49
  • Table 93: EZMix Engage - Product Status 49
  • Table 94: EZMix Engage - Product Description 50
  • Table 95: EZMix Genesis - Product Status 50
  • Table 96: EZMix Genesis - Product Description 50
  • Table 97: EZMix Prodigy - Product Status 51
  • Table 98: EZMix Prodigy - Product Description 51
  • Table 99: Ocu-ject - Product Status 51
  • Table 100: Ocu-ject - Product Description 52
  • Table 101: Unifill Finesse - Product Status 52
  • Table 102: Unifill Finesse - Product Description 52
  • Table 103: Unifill Select - Product Status 53
  • Table 104: Unifill Select - Product Description 53
  • Table 105: Unitract 3ml And 5ml With Luer Needle - Product Status 53
  • Table 106: Unitract 3ml And 5ml With Luer Needle - Product Description 53
  • Table 107: University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview 54
  • Table 108: Microfabricated Microneedle - Product Status 54
  • Table 109: Microfabricated Microneedle - Product Description 54
  • Table 110: University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview 55
  • Table 111: Painless Injection Device - Product Status 55
  • Table 112: Painless Injection Device - Product Description 55
  • Table 113: University of Louisville Pipeline Products & Ongoing Clinical Trials Overview 56
  • Table 114: Ergonomic Syringe - Product Status 56
  • Table 115: Ergonomic Syringe - Product Description 56
  • Table 116: University of Massachusetts Amherst Pipeline Products & Ongoing Clinical Trials Overview 57
  • Table 117: Syringe Needle Injection System - Product Status 57
  • Table 118: Syringe Needle Injection System - Product Description 57
  • Table 119: University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 58
  • Table 120: MicroNeedles - Product Status 58
  • Table 121: MicroNeedles - Product Description 58
  • Table 122: Virginia Commonwealth University Pipeline Products & Ongoing Clinical Trials Overview 59
  • Table 123: Dual-Vial Injection Device - Product Status 59
  • Table 124: Dual-Vial Injection Device - Product Description 59
  • Table 125: Glossary 180

1.2 List of Figures

  • Figure 1: Syringes and Needles - Pipeline Products by Stage of Development 11
  • Figure 2: Syringes and Needles - Pipeline Products by Segment 12
  • Figure 3: Syringes and Needles - Pipeline Products by Territory 13
  • Figure 4: Syringes and Needles - Pipeline Products by Regulatory Path 14
  • Figure 5: Syringes and Needles - Pipeline Products by Estimated Approval Date 15
目次
Product Code: GDME0633EPD

GlobalData's Medical Devices sector report, "Syringes and Needles - Medical Devices Pipeline Assessment, 2018" provides an overview of Syringes and Needles currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Syringes and Needles pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Syringes and Needles under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Syringes and Needles and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Syringes and Needles under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date.

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 7
  • 1.2 List of Figures 9

2 Introduction 10

  • 2.1 Syringes and Needles Overview 10

3 Products under Development 11

  • 3.1 Syringes and Needles - Pipeline Products by Stage of Development 11
  • 3.2 Syringes and Needles - Pipeline Products by Segment 12
  • 3.3 Syringes and Needles - Pipeline Products by Territory 13
  • 3.4 Syringes and Needles - Pipeline Products by Regulatory Path 14
  • 3.5 Syringes and Needles - Pipeline Products by Estimated Approval Date 15

4 Syringes and Needles - Pipeline Products under Development by Companies 16

  • 4.1 Syringes and Needles Companies - Pipeline Products by Stage of Development 16
  • 4.2 Syringes and Needles - Pipeline Products by Stage of Development 18

5 Syringes and Needles Companies and Product Overview 20

  • 5.1 Aquabiliti Company Overview 20
  • 5.2 ARTE CORPORATION Company Overview 22
  • 5.3 Baxter International Inc Company Overview 23
  • 5.4 Becton Dickinson and Co Company Overview 24
  • 5.5 Cincinnati Children's Hospital Medical Center Company Overview 26
  • 5.6 Daxor Corp Company Overview 28
  • 5.7 Galderma SA Company Overview 29
  • 5.8 Globe Medical Tech Inc (Inactive) Company Overview 30
  • 5.9 Injeq Oy Company Overview 32
  • 5.10 iScience Interventional Inc Company Overview 33
  • 5.11 Johns Hopkins University Company Overview 34
  • 5.12 Medigard Ltd Company Overview 35
  • 5.13 MonuMedical LLC Company Overview 38
  • 5.14 Neuroelectrics Company Overview 39
  • 5.15 NuvOx Pharma LLC Company Overview 40
  • 5.16 Olberon Medical Innovation SAS Company Overview 41
  • 5.17 Protectus Medical Devices, Inc. Company Overview 42
  • 5.18 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Company Overview 43
  • 5.19 Rutgers The State University of New Jersey Company Overview 44
  • 5.20 Silmag SA Company Overview 45
  • 5.21 Syrindicare, Inc Company Overview 46
  • 5.22 Telezon Ltd Company Overview 47
  • 5.23 Unilife Corporation Company Overview 49
  • 5.24 University of California Berkeley Company Overview 54
  • 5.25 University of California Irvine Company Overview 55
  • 5.26 University of Louisville Company Overview 56
  • 5.27 University of Massachusetts Amherst Company Overview 57
  • 5.28 University of South Florida Company Overview 58
  • 5.29 Virginia Commonwealth University Company Overview 59

6 Syringes and Needles- Recent Developments 60

  • 6.1 Jun 27, 2018: BD, Heart to Heart International and the NAFC Announce 2018 Grantees for a Multi-Year Point of Care Testing Initiative to Improve Patient Outcomes 60
  • 6.2 Jun 25, 2018: Zimmer Biomet Update on Warsaw North Campus FDA Inspection 61
  • 6.3 Jun 21, 2018: Clinical Innovations to Host Forum, Demonstrate Products at Association of Women's Health, Obstetric and Neonatal Nurses Convention 61
  • 6.4 Jun 21, 2018: West Pharmaceutical Services names Bernard Birkett As Chief Financial Officer 62
  • 6.5 Jun 19, 2018: Cardinal Health Foundation Awards Over $3 Million to More Than 70 Nonprofit Organizations to Fight the Opioid Epidemic across Appalachia 62
  • 6.6 Jun 12, 2018: Daxor Names Kathryn A. Kornafel As Vice President Of Marketing And Commercial Development 64
  • 6.7 Jun 08, 2018: B. Braun to Showcase Its Commitment to Reducing Healthcare-Associated Infections with Products and Education at APIC 2018 65
  • 6.8 Jun 05, 2018: Medtronic Presents Strategic Growth Roadmap at 2018 Investor Day; Outlines Plan to Create Shareholder Value 66
  • 6.9 Jun 01, 2018: BD Appoints John DeFord As Chief Technology Officer 66
  • 6.10 May 31, 2018: Merit Medical Announces Leadership Change and Appointment of Interim CFO 67
  • 6.11 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results 67
  • 6.12 May 18, 2018: West Introduces New Analytical Services Capabilities 70
  • 6.13 May 16, 2018: Zimmer Biomet Statement on Warsaw North Campus FDA Inspection 70
  • 6.14 May 15, 2018: Retractable Technologies Announces Results as of March 31, 2018; Operating Loss Declined by 86.4% 70
  • 6.15 May 14, 2018: Amphastar Pharmaceuticals Receives FDA Approval for Calcium Chloride Injection 71
  • 6.16 May 11, 2018: Terumo Appoints its U.S.-based Subsidiary's Associate as the Fifth Terumo Fellow 71
  • 6.17 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy 72
  • 6.18 May 03, 2018: BD Announces Results For 2018 Second Fiscal Quarter; Raises Fiscal 2018 Guidance 72
  • 6.19 May 03, 2018: Cardinal Health Announces Third-quarter Results for Fiscal Year 2018 74
  • 6.20 Apr 30, 2018: Analytica: Appendix 4C - Quarterly Cash Flow Report 75
  • 6.21 Apr 27, 2018: BD Names Three Executives to Segment Leadership Roles 76
  • 6.22 Apr 26, 2018: Zimmer Biomet Reports First Quarter 2018 Financial Results 77
  • 6.23 Apr 26, 2018: West Announces First-Quarter 2018 Results 78
  • 6.24 Apr 25, 2018: Merit Medical Reports First Quarter of 2018 Financial Results 80
  • 6.25 Apr 25, 2018: CONMED Announces First Quarter 2018 Financial Results 81
  • 6.26 Apr 25, 2018: KARL STORZ OR1 Operating Rooms - Now Assisting the Surgical Team at Spital Thun, Switzerland 82
  • 6.27 Apr 24, 2018: Vitrolife: Interim Report January - March 2018: High Profitability and Time-lapse Growth 83
  • 6.28 Apr 20, 2018: Cook Medical Appoints Christina Anne Vice President of Distribution Channel Management 83
  • 6.29 Apr 18, 2018: B. Braun Opens Five New Medical Production Facilities in Penang 83
  • 6.30 Apr 17, 2018: SCHOTT Introduces syriQ BioPure for Sensitive Drugs 84
  • 6.31 Apr 17, 2018: Guangzhou Improve Medical, a leading global IVD company, receives FDA registration renewal 85
  • 6.32 Apr 13, 2018: Medisystems Announces US Release of MasterGuard Plus 85
  • 6.33 Apr 12, 2018: Gerresheimer raises earnings per share in first quarter due to US tax reform 86
  • 6.34 Apr 09, 2018: RMS Medical Products Victory as U.S. Federal Circuit Court of Appeals Invalidates EMED Technologies Corp.'s Patent, Nullifying Infringement Claim 87
  • 6.35 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics 88
  • 6.36 Apr 02, 2018: Retractable Technologies Reports Results for the Year 2017 88

7 Appendix 178

  • 7.1 Methodology 178
  • 7.2 About GlobalData 181
  • 7.3 Contact Us 181
  • 7.4 Disclaimer 181
Back to Top